News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardioDx, Inc. Uses Revolution Analytics to Develop First Non-Intrusive Test for Predicting Coronary Artery Disease


1/19/2011 10:49:35 AM

(BUSINESS WIRE)--Revolution Analytics, the leading provider of commercial software and support for the popular open source R statistics language, today announced the successful implementation of its signature product, Revolution R Enterprise, by biostatisticians at CardioDX, a genomic research firm. Revolution R was used to design the Corus CAD® test, the first test of its kind to analyze genomic data and identify at-risk patients for coronary artery disease (CAD) without requiring an invasive procedure. The Corus CAD® test was recently honored as one of TIME Magazine’s “Top Ten Medical Breakthroughs of 2010”.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES